Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 06 1995, 1580-1583, Vol 33, No. 6
JR Arribas, DB Clifford, CJ Fichtenbaum, RL Roberts, WG Powderly and GA Storch
The diagnostic utility of Epstein-Barr virus (EBV) DNA detection in
cerebrospinal fluid for the diagnosis of central nervous system lymphoma
was evaluated with two different PCR assays to test a collection of
cerebrospinal fluid samples from 24 AIDS patients with central nervous
system disorders. A PCR assay amplifying a fragment from the BamHI-W region
had the highest clinical and analytic sensitivity. The BamHI-W PCR assay
detected EBV DNA in cerebrospinal fluid from 83% (5 of 6) of patients with
pathologically proven primary central nervous system lymphoma and 7% (1 of
16) of controls with autopsy-proven nonlymphomatous central nervous system
disorders. EBV DNA was also detected in one patient with autopsy-proven
systemic lymphoma involving the central nervous system and one patient with
probable primary central nervous system lymphoma. EBV DNA was detected
consistently when central nervous system lymphoma involved meningeal
surfaces. PCR for EBV in cerebrospinal fluid appears to be useful for
diagnosis of AIDS-related central nervous system lymphoma, but additional
studies are required to better define the sensitivity of the assay and to
understand the significance of a positive test in the absence of lymphoma.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphoma
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63138, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|